TEAD transcription factor family emerges as a promising therapeutic target for oral squamous cell carcinoma

Shuang Wang1,2, Dan Shao3, Xiaoyan Gao4

  • 1Department of Stomatology, Qingdao West Coast New District Central Hospital, Qingdao, China.

Frontiers in Immunology
|October 21, 2024
PubMed

Insights

Targeting TEAD transcription factors offers a promising new strategy for oral squamous cell carcinoma (OSCC) treatment. Research highlights TEAD

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Oral squamous cell carcinoma (OSCC) treatment has seen no survival rate improvement in 50 years, necessitating novel therapeutic targets.
  • TEAD transcription factors are vital in development and homeostasis, but also promote tumor progression by regulating genes like Cyr61 and Myc.
  • TEAD's association with clinical parameters in various cancers, including OSCC, establishes it as a potential predictive biomarker.

Purpose of the Study:

  • To review current targeted therapy strategies for OSCC.
  • To elucidate the role of TEAD transcription factors in OSCC oncogenic signaling pathways.
  • To analyze the potential of TEAD as an innovative therapeutic target and biomarker for OSCC.

Main Methods:

  • Literature review of TEAD transcription factors' role in OSCC.
  • Analysis of TEAD's involvement in oncogenic signaling pathways.
  • Evaluation of existing TEAD-targeting drugs and their efficacy.

Main Results:

  • TEAD transcription factors are implicated in OSCC progression through gene regulation.
  • TEAD is a significant biomarker correlating with clinical parameters in OSCC.
  • Existing TEAD-targeting drugs show encouraging results, suggesting TEAD's therapeutic potential.

Conclusions:

  • TEAD transcription factors represent a viable and innovative therapeutic target for OSCC.
  • Targeting TEAD offers a promising avenue for improving OSCC treatment outcomes.
  • Further clinical applications of TEAD-based therapies for OSCC warrant investigation.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
10.9K
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.2K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
75.7K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K